USE OF TWO BLOOD-BASED BIOMARKER TESTS IN SERIES TO RECLASSIFY RISK OF INDETERMINATE PULMONARY NODULES

被引：0
|
作者：
Pitcher, Trevor
Jett, James
Springmeyer, Steven
Doubleday, Kevin
Peek, Laura
机构：
来源：
CHEST | 2020年 / 158卷 / 04期
关键词：
D O I：
10.1016/j.chest.2020.08.1331
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1476A / 1477A
页数：2
相关论文
共 50 条
  • [1] USE OF A BLOOD-BASED BIOMARKER FOR INDETERMINATE PULMONARY NODULES IN COMMUNITY SETTINGS
    Long, Kathryn J.
    Tanner, Nichole T.
    Pitcher, Trevor
    Silvestri, Gerard A.
    CHEST, 2024, 166 (04) : 4358A - 4359A
  • [2] Validation of Blood-Based Biomarker for Classification of Patients with Indeterminate Pulmonary Nodules
    Tomic, Jennifer L.
    Lagier, Robert L.
    Pass, Harvey I.
    Rom, William N.
    Pollard, Thomas R.
    Birse, Charlie E.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S306 - S307
  • [3] Contribution of a Blood-Based Protein Biomarker Panel to the Classification of Indeterminate Pulmonary Nodules
    Ostrin, Edwin J.
    Bantis, Leonidas E.
    Wilson, David O.
    Patel, Nikul
    Wang, Renwei
    Kundnani, Deepali
    Adams-Haduch, Jennifer
    Dennison, Jennifer B.
    Fahrmann, Johannes F.
    Chiu, Hsienchang Thomas
    Gazdar, Adi
    Feng, Ziding
    Yuan, Jian-Min
    Hanash, Samir M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (02) : 228 - 236
  • [4] BUDGET IMPACT OF A BLOOD-BASED INTEGRATED CLASSIFIER TEST TO RECLASSIFY RISK OF PULMONARY NODULES IN A US COMMERCIAL PAYER SETTING
    Smith, M.
    Le, K.
    Campbell, D.
    Migliaccio-Walle, K.
    Kang, A.
    Springmeyer, S.
    VALUE IN HEALTH, 2023, 26 (06) : S88 - S88
  • [5] A Modified Combined Biomarker Model for the Risk Stratification of Indeterminate Pulmonary Nodules
    Paez, R.
    Kammer, M. N.
    Chen, H.
    Deppen, S. A.
    Maldonado, F.
    Baron, A. E.
    Grogan, E. L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [6] Biomarker Informed Management of Indeterminate Pulmonary Nodules with a Combined Clinical, Blood and Imaging-Based Biomarker Strategy
    Kammer, M.
    Lakhani, D.
    Balar, A.
    Antic, S.
    Kussrow, A. K.
    Webster, R. L.
    Mahapatra, S.
    Barad, U.
    Shah, C.
    Atwater, T.
    Diergaarde, B.
    Qian, J.
    Kaizer, A.
    Balagurunathan, Y.
    Helmey, S.
    Chen, S.
    Bauza, J.
    Deppen, S.
    Sandler, K. L.
    Maldonado, F.
    Spira, A.
    Billatos, E.
    Schabath, M. B.
    Gillies, R.
    Wilson, D.
    Grogan, E. L.
    Landman, B.
    Baron, A.
    Chen, H.
    Bornhop, D. J.
    Massion, P. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [7] A Four-protein Blood Biomarker Panel Refines a Clinical Risk Score for Indeterminate Pulmonary Nodules
    Ostrin, E.
    Fahrmann, J.
    Vykoukal, J.
    Dennison, J.
    Nargund, R.
    Toumazis, I.
    Baron, A.
    Irajizad, E.
    Hanash, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [8] COMPARISON OF A HIGH SPECIFICITY BLOOD-BASED BIOMARKER WITH PET/CT FOR IDENTIFYING MALIGNANT PULMONARY NODULES
    Long, Kathryn
    Pitcher, Trevor
    Kammer, Michael
    Nair, Viswam S.
    Silvestri, Gerard A.
    CHEST, 2023, 164 (04) : 4186A - 4187A
  • [9] Risk Assessment for Indeterminate Pulmonary Nodules Using a Novel, Plasma-Protein Based Biomarker Assay
    Fish, A.
    Vachani, A.
    Beggs, M.
    Carbonell, L.
    Haddad, Z.
    Juang, A.
    Kamer, S.
    Patel, B.
    Yu, H.
    Wu, A.
    Massion, P.
    Arjomandi, M.
    Brown, J.
    Trivedi, N.
    Rubenstein, T.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S439 - S439
  • [10] Analytical Validation of the LungLB Test: A Blood-Based 4-Color FISH Assay for the Evaluation of Indeterminate Pulmonary Nodules
    Vail, E.
    Lutman, M.
    Gramajo-Leventon, D.
    Tahvilian, S.
    Baden, L.
    Gilbert, C.
    Trejo, M.
    Donovan, M.
    Katchman, B.
    Pagano, P.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S98 - S99
12345